Vasodilator Therapies in the Treatment of Acute Heart Failure
Purpose of Review Vasodilators are commonly recommended to treat acute heart failure (AHF), yet they are infrequently used. This review aims to evaluate the clinical utility of traditional, historical, and novel vasodilators in the treatment of AHF. Recent Findings No traditional vasodilator (i.e., nitroglycerin) therapy definitely improves short- or long-term outcomes. Despite repeated efforts to develop new pharmacologic treatments, no novel therapy outperforms traditional management. At the present time, we continue to recommend traditional vasodilators, such as nitroglycerin. Summary The use of select vasodilators in the treatment of AHF improves hemodynamics and provides short-term relief; however, data regarding long-term benefits is lacking..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Current heart failure reports - 16(2019), 1 vom: Feb., Seite 32-37 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Holt, Daniel B. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2019 |
|---|
| doi: |
10.1007/s11897-019-0421-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2028958979 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2028958979 | ||
| 003 | DE-627 | ||
| 005 | 20230517081459.0 | ||
| 007 | tu | ||
| 008 | 200819s2019 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11897-019-0421-4 |2 doi | |
| 035 | |a (DE-627)OLC2028958979 | ||
| 035 | |a (DE-He213)s11897-019-0421-4-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Holt, Daniel B. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vasodilator Therapies in the Treatment of Acute Heart Failure |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2019 | ||
| 520 | |a Purpose of Review Vasodilators are commonly recommended to treat acute heart failure (AHF), yet they are infrequently used. This review aims to evaluate the clinical utility of traditional, historical, and novel vasodilators in the treatment of AHF. Recent Findings No traditional vasodilator (i.e., nitroglycerin) therapy definitely improves short- or long-term outcomes. Despite repeated efforts to develop new pharmacologic treatments, no novel therapy outperforms traditional management. At the present time, we continue to recommend traditional vasodilators, such as nitroglycerin. Summary The use of select vasodilators in the treatment of AHF improves hemodynamics and provides short-term relief; however, data regarding long-term benefits is lacking. | ||
| 650 | 4 | |a Acute heart failure | |
| 650 | 4 | |a Vasodilator(s) | |
| 700 | 1 | |a Pang, Peter S. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current heart failure reports |d Springer US, 2004 |g 16(2019), 1 vom: Feb., Seite 32-37 |w (DE-627)390611905 |w (DE-600)2151202-4 |x 1546-9530 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2019 |g number:1 |g month:02 |g pages:32-37 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11897-019-0421-4 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2019 |e 1 |c 02 |h 32-37 | ||